While this new benefit-risk guideline opens a door to partner with patients for conducting preference studies and to structure patient-focused benefit-risk assessment, we cannot forget that there is a lack of obligation to put these guidelines into effect, and how exactly patient communities and their representatives can get involved in this?
Natacha Bolaños
Natacha Bolanos reports about her experience as a patient expert and EUPATI course participant. Natacha is a cancer rehabilitation specialist who works as a patient peer helper in lymphoma, myeloma and leukemia.
About Natacha Bolaños
Natacha Bolanos reports about her experience as a patient expert and EUPATI course participant. Natacha is a cancer rehabilitation specialist who works as a patient peer helper in lymphoma, myeloma and leukemia.
